Sullivan Ryan T
Insider CIK 1578823 · ICPT General Counsel and Secretary · WCRX VP, General Counsel & Secr. · ANAC Sr. VP and General Counsel
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ICPT INTERCEPT PHARMACEUTICALS, | F Tax w/h | 2020-11-13 | 2020-11-16 | 493 | $37.87 | $18.7K | 24,708 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | F Tax w/h | 2020-08-13 | 2020-08-14 | 493 | $51.86 | $25.6K | 25,201 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | F Tax w/h | 2020-05-13 | 2020-05-14 | 493 | $85.08 | $41.9K | 25,694 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | F Tax w/h | 2020-02-13 | 2020-02-14 | 493 | $94.69 | $46.7K | 26,187 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | A Award deriv | 2020-01-23 | 2020-01-27 | 9,200 | — | $0 | 9,200 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | A Award | 2020-01-23 | 2020-01-27 | 5,600 | — | $0 | 26,680 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | F Tax w/h | 2019-12-31 | 2020-01-03 | 809 | $123.92 | $100.3K | 21,080 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | M Exercise deriv | 2019-11-19 | 2019-11-19 | 8,325 | — | $0 | 26,475 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | S Sale | 2019-11-19 | 2019-11-19 | 3,829 | $85.00 | $325.5K | 21,889 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | M Exercise | 2019-11-19 | 2019-11-19 | 8,325 | $53.41 | $444.6K | 34,043 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | S Sale | 2019-11-19 | 2019-11-19 | 8,325 | $85.00 | $707.6K | 25,718 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | M Exercise deriv | 2019-11-13 | 2019-11-15 | 500 | — | $0 | 34,800 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | F Tax w/h | 2019-11-13 | 2019-11-15 | 711 | $83.92 | $59.7K | 25,718 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | S Sale | 2019-11-13 | 2019-11-15 | 500 | $85.00 | $42.5K | 26,429 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | M Exercise | 2019-11-13 | 2019-11-15 | 500 | $53.41 | $26.7K | 26,929 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | F Tax w/h | 2019-08-13 | 2019-08-14 | 689 | $66.03 | $45.5K | 26,429 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | F Tax w/h | 2019-05-13 | 2019-05-14 | 711 | $83.73 | $59.5K | 27,118 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | F Tax w/h | 2019-02-13 | 2019-02-14 | 1,971 | $110.35 | $217.5K | 27,829 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | A Award deriv | 2019-01-16 | 2019-01-18 | 10,700 | — | $0 | 10,700 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | A Award | 2019-01-16 | 2019-01-18 | 6,600 | — | $0 | 29,800 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | A Award deriv | 2018-02-13 | 2018-02-15 | 35,300 | — | $0 | 35,300 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | A Award | 2018-02-13 | 2018-02-15 | 23,200 | — | $0 | 23,200 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | D To issuer deriv | 2016-06-24 | 2016-06-24 | 6,350 | — | $0 | 0 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | D To issuer deriv | 2016-06-24 | 2016-06-24 | 6,250 | — | $0 | 0 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | D To issuer deriv | 2016-06-24 | 2016-06-24 | 30,000 | — | $0 | 0 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | D To issuer deriv | 2016-06-24 | 2016-06-24 | 24,360 | — | $0 | 0 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | D To issuer deriv | 2016-06-24 | 2016-06-24 | 31,623 | — | $0 | 0 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | D To issuer | 2016-06-24 | 2016-06-24 | 30,132 | $99.25 | $2.99M | 0 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | S Sale | 2016-04-29 | 2016-04-29 | 3,125 | $66.33 | $207.3K | 30,132 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | A Award deriv | 2016-02-03 | 2016-02-05 | 31,623 | — | $0 | 31,623 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | A Award deriv | 2016-02-03 | 2016-02-05 | 6,250 | — | $0 | 6,250 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | A Award | 2016-02-03 | 2016-02-05 | 6,250 | — | $0 | 33,257 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | S Sale | 2016-01-04 | 2016-01-05 | 200 | $112.69 | $22.5K | 27,007 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | S Sale | 2016-01-04 | 2016-01-05 | 200 | $110.44 | $22.1K | 27,540 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | S Sale | 2016-01-04 | 2016-01-05 | 333 | $112.05 | $37.3K | 27,207 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | M Exercise deriv | 2015-12-10 | 2015-12-11 | 10,000 | — | $0 | 30,000 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | M Exercise | 2015-12-10 | 2015-12-11 | 10,000 | $15.30 | $153.0K | 37,740 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | S Sale | 2015-12-10 | 2015-12-11 | 1,100 | $108.90 | $119.8K | 36,640 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | S Sale | 2015-12-10 | 2015-12-11 | 4,900 | $110.25 | $540.2K | 31,740 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | S Sale | 2015-12-10 | 2015-12-11 | 4,000 | $111.03 | $444.1K | 27,740 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | S Sale | 2015-04-29 | 2015-05-01 | 3,125 | $53.61 | $167.5K | 27,740 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | A Award deriv | 2015-02-03 | 2015-02-05 | 24,360 | — | $0 | 24,360 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | A Award deriv | 2015-02-03 | 2015-02-05 | 6,350 | — | $0 | 6,350 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | A Award | 2015-02-03 | 2015-02-05 | 5,865 | — | $0 | 30,865 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | A Award deriv | 2014-04-28 | 2014-04-29 | 40,000 | — | $0 | 40,000 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | A Award | 2014-04-28 | 2014-04-29 | 25,000 | $15.30 | $382.5K | 25,000 | SEC↗ |
| WCRX Warner Chilcott plc | D To issuer | 2013-10-01 | 2013-10-01 | 18,040 | — | $0 | 0 | SEC↗ |
| WCRX Warner Chilcott plc | D To issuer deriv | 2013-09-30 | 2013-10-01 | 8,170 | — | $0 | 0 | SEC↗ |
| WCRX Warner Chilcott plc | D To issuer deriv | 2013-09-30 | 2013-10-01 | 2,193 | — | $0 | 0 | SEC↗ |
| WCRX Warner Chilcott plc | D To issuer deriv | 2013-09-30 | 2013-10-01 | 1,065 | — | $0 | 0 | SEC↗ |
| WCRX Warner Chilcott plc | D To issuer deriv | 2013-09-30 | 2013-10-01 | 6,610 | — | $0 | 0 | SEC↗ |
| WCRX Warner Chilcott plc | D To issuer deriv | 2013-09-30 | 2013-10-01 | 15,730 | — | $0 | 0 | SEC↗ |
| WCRX Warner Chilcott plc | D To issuer deriv | 2013-09-30 | 2013-10-01 | 28,860 | — | $0 | 0 | SEC↗ |
| WCRX Warner Chilcott plc | D To issuer deriv | 2013-09-30 | 2013-10-01 | 8,990 | — | $0 | 0 | SEC↗ |
| WCRX Warner Chilcott plc | D To issuer | 2013-09-30 | 2013-10-01 | 8,420 | — | $0 | 18,040 | SEC↗ |
| WCRX Warner Chilcott plc | S Sale | 2013-07-01 | 2013-07-02 | 169 | $19.88 | $3.4K | 26,460 | SEC↗ |